Chronic, recurrent Lymphocytic Leukemia Completed Phase 3 Trials for Sirolimus (DB00877)

Also known as: Recurrent Chronic Lymphocytic Leukemia

IndicationStatusPhase
DBCOND0112002 (Chronic, recurrent Lymphocytic Leukemia)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01231412Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell TransplantTreatment